⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ERAS News
Erasca, Inc. Common Stock
Functional Force: Precision Platforms Disrupt the 2026 Tumor Landscape
prnewswire.com
GTBP
IBRX
ERAS
CHRS
NBP
Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff
prnewswire.com
ONCY
NRIX
ERAS
FHTX
ORIC
Erasca Announces Promising Early Clinical Data for ERAS-0015 and 2026-2027 Milestones
globenewswire.com
ERAS
Erasca to Present at the 44th Annual J.P. Morgan Healthcare Conference
globenewswire.com
ERAS
Platform Technologies Drive $211B Surge in Precision Cancer Treatment
prnewswire.com
GTBP
ERAS
FHTX
OABI
RXRX
Erase.com Recognized as a Best Workplace and Earns Strong Employee Support
accessnewswire.com
ERAS
Erasca to Present at the 8th Annual Evercore Healthcare Conference
globenewswire.com
ERAS
Erasca Reports Third Quarter 2025 Business Updates and Financial Results
globenewswire.com
ERAS
Erasca Announces Issuance of a U.S. Patent Covering Pan-RAS Molecular Glue ERAS-0015
globenewswire.com
ERAS
Erasca to Present at Upcoming Conferences in November
globenewswire.com
ERAS